Back
Hutchmed
Founded by : -, 1 January 2000
About the Company
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. A dedicated organization of over 1,300 personnel has advanced ten cancer drug candidates from in-house discovery into clinical studies around the world, with its first three oncology drugs now approved and launched. For more information, please visit: www.hutch-med.com or follow us here on LinkedIn.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, Hutchmed’s industry classification falls within the following categories:
- Sector: -
- Industry group: -
- Industry: -
- Sub-Industry: -
Videos and Photos
Company Address
Hong Kong, Central, Harcourt Rd, 10號, Hutchison House, 21樓
Source : Google maps